Brazil’s Anvisa approves Russian Sputnik V vaccine, with conditions

Brazilian health regulator Anvisa on Friday gave the green light for states to import the Russian COVID-19 vaccine Sputnik V, but with conditions attached.

Anvisa’s board voted 4-1 to grant the conditional approval after more than seven hours of deliberation, following the recommendation of its technical staff earlier in the day.

By Jamie McGeever and Lisandra Paraguassu via Reuters

Read full article here

Share This

Chamber Updates Stay connected with Chamber activities